1,217
Participants
Start Date
December 31, 2004
Primary Completion Date
May 31, 2007
Study Completion Date
December 31, 2016
Rituximab
rituximab 375 mg/m2 every 8 weeks for 24 months (12 injections) or control with no treatment
Hématologie CHU Purpan, Toulouse
Polyclinique Bordeaux Nord, Bordeaux
Centre Hospitalier Robert Debré, Reims
Hématologie CHU de Lille, Lille
Centre Léon Bérard, Lyon
Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite
Institut Curie, Paris
Hôpital Saint Louis, Paris
Hématologie Adultes - Hôpital Necker, Paris
Centre Henri Becquerel, Rouen
Hôpital Henri Mondor, Créteil
Fundaleu Hospital, Buenos Aires
Australian Leukemia and Lymphoma Group, Melbourne
Université de Gent, Ghent
Groupe d'Etude des Lymphomes de l'adulte, Mont-Godinne
Hospital Samaritano, São Paulo
Fundación Santafé de Bogotá, Bogotá
Amtssygehuset i Herlev, Herlev
Institut Gustave Roussy, Villejuif
HOVON, Utrecht
Australia New Zealand Leukemia Lymphoma Group, Auckland
Instituo Nacional de Enfermedades Neoplasicas, Lima
Hospital Clinic Barcelona, Barcelona
King Chulalongkorn Memorial Hospital, Bangkok
HOVON - Dutch Haemato-Oncology Association
OTHER
German Low Grade Lymphoma Study Group
OTHER
Australasian Leukaemia and Lymphoma Group
OTHER
Institute of Cancer Research, United Kingdom
OTHER
Lymphoma Study Association
OTHER